Table of contents
February 2005 Vol 5 No 2
In this issue
p81 | doi:10.1038/nrc1564
Research Highlights
Genetics: Family connections
p83 | doi:10.1038/nrc1557
Cancer genetics: Tumour-suppressor super models
p84 | doi:10.1038/nrc1554
Oncolytic viruses: Export license
p84 | doi:10.1038/nrc1555
In the news
Ready for the end?
p84 | doi:10.1038/nrc1562
In brief
Early detection | Prognosis | Cancer stem cells | Early diagnosis
p85 | doi:10.1038/nrc1561
DNA repair: Lethal variations
p86 | doi:10.1038/nrc1553
Immunotherapy: Memory
p86 | doi:10.1038/nrc1556
Carcinogenesis: Catch-22
p87 | doi:10.1038/nrc1552
Trial Watch
Metastasis profiles
p87 | doi:10.1038/nrc1559
Metastasis: Deciphering signatures
p88 | doi:10.1038/nrc1558
Oncogenes: Addicted to MYC?
p88 | doi:10.1038/nrc1560
Therapeutics: On the TRAIL of death
p89 | doi:10.1038/nrc1544
Reviews
The search for the retinoblastoma cell of origin
Michael A. Dyer & Rod Bremner
p91 | doi:10.1038/nrc1545
Bleomycins: towards better therapeutics
Jingyang Chen & JoAnne Stubbe
p102 | doi:10.1038/nrc1547
Nature and nurture – lessons from chemical carcinogenesis
Andreas Luch
p113 | doi:10.1038/nrc1546
Perspectives
Opinion
Profiling early head and neck cancer
Keith D. Hunter, E. Ken Parkinson & Paul R. Harrison
p127 | doi:10.1038/nrc1549
Innovation
Control of DNA replication and its potential clinical exploitation
Michael A. Gonzalez, Kiku-e K. Tachibana, Ronald A. Laskey & Nicholas Coleman
p135 | doi:10.1038/nrc1548
Opinion
Bias as a threat to the validity of cancer molecular-marker research
David F. Ransohoff
p142 | doi:10.1038/nrc1550
Correspondence
Correspondence: T cells with potential to target metastatic cells
Elisabeth Z. Wolpert & Pascal Dammeyer
| doi:10.1038/nrc1359-c1